Upregulation of HDAC3 is found in injured podocytes, renal fibrosis, chronic kidney diseases (CKDs), and various cancers, indicating that HDAC3 is a promising target in several diseases [9]. This evidence concerns the gene HDAC3 and chronic kidney disease.